Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
Eukaryotic protein degradation by the proteasome and the lysosome is a dynamic and complex process in which ubiquitin has a key regulatory role. The distinctive morphology of the postmitotic neuron creates unique challenges for protein degradation systems with respect to cell-surface protein turnover and substrate delivery to proteolytic machineries that are required for both synaptic plasticity and self-renewal. Moreover, the discovery of ubiquitin-positive protein aggregates in a wide spectrum of neurodegenerative diseases underlines the importance and vulnerability of the degradative system in neurons. In this article, we discuss the molecular mechanism of protein degradation in the neuron with respect to both its function and its dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of proteasome activity has been experimentally shown to disrupt synapse composition, promote the aggregation of polyubiquitinated proteins, and ultimately lead to neurodegeneration6.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [6]
In the citing paper
“Effective protein clearance by the proteasome is crucial for various neuronal processes, including synaptic remodeling, cell migration, neurotransmitter release, long-term potentiation, long-term depression, and memory formation5,6.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [6]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840 · cited 1×
“jpg" NDATA ITEM> ]> Eukaryotic cells have evolved complex machineries for protein degradation, and the precise regulation of degradation underlies many fundamental cellular processe”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146 · cited 1×
“Synaptic plasticity and protein turnover As early as 1949, Hebb postulated that “some growth process or metabolic change” may underlie activity-dependent modifications of neuronal connectivit”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“cgi?id=168600">PD ) diseases, are associated with abnormal protein aggregates, implicating degradative dysfunctio”
BackgroundImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Lysosomes: fusion and function
Luzio, J. P., Pryor, P. R., & Bright, N. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2217 · Cited by 1,740 · cited 1×
“2 ) degrades most membrane and endocytosed protein”
BackgroundRecognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716 · cited 1×
“The ubiquitin-chain length was between one and three ubiquitins; K48 chains of four ubiquitins or longer are required for efficient targeting to the proteasom”
BackgroundThe roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · cited 1×
“cgi?id=168600">PD ) diseases, are associated with abnormal protein aggregates, implicating degradative dysfunctio”
BackgroundA proteomics approach to understanding protein ubiquitination
Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D., & Gygi, S. P. (2003) · Nature Biotechnology · doi:10.1038/nbt849 · Cited by 1,602
Research works printed but not linked: 1
- Walkley, S. U. in Neurobiology of Disease (ed. Gilman, S.) 1–18 (Elsevier, Burlington, 2007).
Cited by
Items 201–300 of 551
Lee, J. A., Son, H. J., Choi, J., Kim, J., Han, S. H., Shin, N., Kim, J. H., Kim, S., Heo, J. Y., Kim, D. J., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.11.006 · Cited by 31
“Since neurons are particularly prone to damages by protein aggregates, abnormal proteins need to be efficiently removed by the proteasome system (Tai and Schuman, 2008).”
BackgroundLysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy
Walkley, S. U., Sikora, J., Micsenyi, M. C., Davidson, C. D., & Dobrenis, K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381436 · Cited by 31
Temporal phases of long-term potentiation (LTP): myth or fact?
Abbas, A.-K., Villers, A., & Ris, L. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0072 · Cited by 34
Park, H., Yang, J., Kim, R., Li, Y., Lee, Y., Lee, C., Park, J., Lee, D., Kim, H., & Kim, E. (2015) · Scientific Reports · doi:10.1038/srep16410 · Cited by 31
The role of the ubiquitin proteasome system in the memory process
Lip, P. Z. Y., Demasi, M., & Bonatto, D. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.11.013 · Cited by 32
“Once ubiquitinated, proteasomal degradation of PKA is promoted by Aplysia ubiquitin C-terminal hydrolase, a deubiquitinating enzyme (Tai and Schuman, 2008).”
BackgroundCloherty, A. P. M., Rader, A. G., Compeer, B., & Ribeiro, C. M. S. (2021) · Viruses · doi:10.3390/v13020320 · Cited by 31
“, a polymeric ubiquitin chain formed via linking of the K48 residues of multiple ubiquitin monomers, thereby earmarking the substrate for degradation via the 26S proteasome [106,107].”
BackgroundVelentzas, P. D., Velentzas, A. D., Mpakou, V., Antonelou, M. H., Margaritis, L. H., Papassideri, I. S., & Stravopodis, D. J. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-012-9235-9 · Cited by 33
Long-Term Potentiation in Isolated Dendritic Spines
Corera, A. T., Doucet, G., & Fon, E. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006021 · Cited by 28
Alam, K., Farasyn, T., Crowe, A., Ding, K., & Yue, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186924 · Cited by 30
“In addition to being degraded through the lysosome [11] , membrane proteins, including some membrane-transport proteins, can be degraded via the ubiquitin-proteasome system [12] [13] [14] .”
BackgroundJin, C., Kim, S., Kang, H., Yun, K. N., Lee, Y., Zhang, Y., Kim, Y., Kim, J. Y., & Han, K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14796 · Cited by 30
Subramaniam, M., Kern, B., Vogel, S., Klose, V., Schneider, G., & Roeper, J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12660 · Cited by 31
“Electrical activity in vivo is orchestrated by excitatory and inhibitory synaptic inputs as well as intrinsic excitability, which are both dynamically regulated by protein turnover (Bingol & Schuman, 2006; Tai & Schuman, 2008).”
BackgroundLysosomal Proteins as a Therapeutic Target in Neurodegeneration
Donald, J. M. M., & Krainc, D. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104432 · Cited by 31
Lin, J.-X., Ge, M., Liu, C., Holewinski, R. J., Andrésson, Þ., Yu, Z., Gebregiorgis, T., Spolski, R. J., Li, P., & Leonard, W. J. (2024) · Nature Communications · doi:10.1038/s41467-024-50925-6 · Cited by 30
“5d and Supplementary Data 2), as well as genes encoding for proteosome components 57 – 59 , nuclear import and export 60 (Supplementary Fig.”
Novel deletion at Xq24 including the UBE2A gene in a patient with X-linked mental retardation
Honda, S., Orii, K. O., Kobayashi, J., Hayashi, S., Imamura, A., Imoto, I., Nakagawa, E., Goto, Y., & Inazawa, J. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.14 · Cited by 30
Andrews, J. L., Goodfellow, F. J., Matosin, N., Snelling, M., Newell, K. A., Huang, X., & Fernandez, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.01.009 · Cited by 29
Djagaeva, I., & Doronkin, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007598 · Cited by 29
“Rapid and substrate-specific protein degradation is among the most promising molecular switches to regulate actin remodeling during dendritic development [20,21,22].”
An integrated transcriptomic and proteomic map of the mouse hippocampus at synaptic resolution
Kaulich, E., Waselenchuk, Q., Fürst, N., Desch, K., Mosbacher, J., Ciirdaeva, E., Juengling, M., Ray, R., Nassim-Assir, B., Tushev, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63119-5 · Cited by 30
Self-citationPresynaptic silencing is an endogenous neuroprotectant during excitotoxic insults
Hogins, J., Crawford, D. C., Jiang, X., & Mennerick, S. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.005 · Cited by 27
Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?
Bellavista, E., Andreoli, F., Parenti, M. D., Martucci, M., Santoro, A., Salvioli, S., Capri, M., Baruzzi, A., Río, A. D., Franceschi, C., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581927 · Cited by 28
Cheng, C., Yao, H., Li, H., Liu, J., Liu, Z., Wu, Y., Zhu, L. W., Hu, H., Fang, Z., & Wu, L. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.01.006 · Cited by 27
“We further investigated the role of USP48 in HMGA2 protein stability by examining two major pathways for cellular protein degradation: the ubiquitin ‒ proteasome system and autophagy-lysosome pathway 41 .”
BackgroundCullin 7 mediates proteasomal and lysosomal degradations of rat Eag1 potassium channels
Hsu, P., Ma, Y.-T., Fang, Y.-C., Huang, J.-J., Gan, Y., Chang, P.-T., Jow, G., Tang, C., & Jeng, C. (2017) · Scientific Reports · doi:10.1038/srep40825 · Cited by 29
Serotonergic dystrophy induced by excess serotonin
Daubert, E. A., Heffron, D. S., Mandell, J. W., & Condron, B. G. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.04.001 · Cited by 30
“Growing evidence indicates that aggregate formation in neurodegenerative disease models may be due to defects in or overwhelming of the ubiquitin–proteasome system (UPS) and autophagic clearance machinery in the cell (Martinez-Vincente and Cuervo, 2007; Tai and Schuman, 2008).”
Carmo‐Fonseca, M., Berciano, M. T., & Lafarga, M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000703 · Cited by 32
Logistics of neuronal protein turnover: Numbers and mechanisms
Sun, C., & Schuman, E. M. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103793 · Cited by 27
Self-citationDining in with BCL-2: new guests at the autophagy table
Germain, M., & Slack, R. S. (2009) · Clinical Science · doi:10.1042/cs20090310 · Cited by 26
A neuronal aging pattern unique to humans and common chimpanzees
Gilissen, E., Leroy, K., Yilmaz, Z., Kövari, E., Bouras, C., Boom, A., Poncelet, L., ERWIN, J. M., Sherwood, C. C., Hof, P. R., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0931-5 · Cited by 27
Trophic factor and hormonal regulation of neurite outgrowth in sensory neuron-like 50B11 cells
Bhattacherjee, A., Liao, Z., & Smith, P. G. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.11.018 · Cited by 26
“5, a neuron-specific ubiquitin hydrolase, is believed to play a role in cleaving ubiquitin-protein bonds, which is an important function within growing neurite tips where protein turnover via the ubiquitin-proteasome pathway is high [36].”
BackgroundJantas, D., Roman, A., Kuśmierczyk, J., Lorenc‐Koci, E., Konieczny, J., Lenda, T., & Lasoń, W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9374-z · Cited by 27
“…to various abnormalities in genes [e.g., parkin, ubiquitin C-terminal hydrolase (UCH-L1)] which finally could affects intracellular degradation systems (UPS or autophagy pathways) (Cartier et al. 2012; Gosal et al. 2006; Olzmann and Chin 2008; Tai and Schuman 2008; Whitworth and Pallanck 2009).”
BackgroundLatina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
“…activity controls the formation/maintenance of synaptic connections and, then, the synaptic plasticity by locally regulating the abundance and/or distribution of different classes of pre- and postsynaptic proteins (Hegde, 2004; Patrick, 2006; Tai and Schuman, 2008; Segref and Hoppe, 2009).”
BackgroundChen, Z. S., Wong, A. K. Y., Cheng, T. C., Koon, A. C., & Chan, H. Y. E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14669 · Cited by 30
USP8 Deubiquitinates the Leptin Receptor and Is Necessary for Leptin-Mediated Synapse Formation
Bland, T., Sahin, G. S., Zhu, M., Dillon, C., Impey, S., Appleyard, S. M., & Wayman, G. A. (2019) · Endocrinology · doi:10.1210/en.2019-00107 · Cited by 27
“to the development of synapses in the hippocampus The Ub signaling system controls a diverse set of neuronal functions, including synapse development and function (38, 39, 78).”
BackgroundJantas, D., Lorenc‐Koci, E., Kubera, M., & Lasoń, W. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.05.013 · Cited by 26
Koga, K., Yao, I., Setou, M., & Zhuo, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0023-16.2017 · Cited by 26
“Mechanisms of the UPS including SCRAPPER for LTP The UPS is emerging as a powerful modulator of synaptic function, acting at both presynaptic and postsynaptic sites (Hegde and DiAntonio, 2002; Tai and Schuman, 2008).”
BackgroundShang, K., Zhang, L., Yu, Y., Xiao, H., Gao, Y., Liu, Y., Huang, J. M., Song, H., & Han, H. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100548 · Cited by 27
Grochowska, K. M., Sperveslage, M., Raman, R., Failla, A. V., Głów, D., Schulze, C., Laprell, L., Fehse, B., & Kreutz, M. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112998 · Cited by 26
Wei, Y. B., Melas, P. A., Villaescusa, J. C., Liu, J. J., Xu, N., Christiansen, S. H., Elbrønd-Bek, H., Woldbye, D. P. D., Wegener, G., Mathé, A. A., et al. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw069 · Cited by 28
“Protein ubiquitination is known to play an important role in neuronal function (Tai and Schuman, 2008), Ephrin ligands and their receptors regulate synapse formation and neuronal plasticity (Klein, 2009), and Dopamine-DARPP32 is extensively involved in intracellular signaling pathways and…”
BackgroundEnogieru, A. B., & Momodu, O. I. (2021) · The Botanical Review · doi:10.1007/s12229-021-09246-2 · Cited by 30
Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Nielsen, P. Y., Okarmus, J., & Meyer, M. (2023) · Cells · doi:10.3390/cells12040651 · Cited by 25
“The ubiquitination process involves several enzymes: the E1 ubiquitin‐activating enzyme, the E2 ubiquitin‐conjugating en‐ zyme, and the E3 ubiquitin‐protein ligase, as well as the E3 ubiquitin chain‐elongating subtype [21].”
BackgroundInfluentialAtoh1 regulation in the cochlea: more than just transcription
Cheng, Y. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600438 · Cited by 23
E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway
Yan, J., Yuan, Y., Chu, S., Li, G., & Chen, N. (2018) · Molecules · doi:10.3390/molecules23112839 · Cited by 24
“It has been reported that mutations in Parkin and ubiquitin carboxy-terminal hydrolase L1 in which both are involved in ubiquitin-dependent degradation were associated with inherited PD [30,31].”
BackgroundZajicek, A. S., & Yao, W. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0849-7 · Cited by 24
Presynaptic plasticity at cerebellar parallel fiber terminals.
Guen, M.-C. L., & Zeeuw, C. I. D. (2010) · PubMed · Cited by 29
Kaulich, E., Waselenchuk, Q., Fürst, N., Desch, K., Mosbacher, J., Ciirdaeva, E., Juengling, M., Tushev, G., Langer, J., & Schuman, E. M. (2024) · doi:10.1101/2024.08.05.606570 · Cited by 22
Self-citationThe Ubiquitinated Axon: Local Control of Axon Development and Function by Ubiquitin
Pinto, M. J., Tomé, D., & Almeida, R. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-20.2021 · Cited by 23
“In the brain, the proteasome and ubiquitin control diverse functions, including serving as key regulators of neuronal protein homeostasis (Tai and Schuman, 2008; Bingol and Sheng, 2011).”
BackgroundCereblon inhibits proteasome activity by binding to the 20S core proteasome subunit beta type 4
Lee, K. M., Lee, J., & Park, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.108 · Cited by 25
Alghamdi, A. A., Vallortigara, J., Howlett, D. R., Broadstock, M., Hortobágyi, T., Ballard, C. G., Thomas, A. J., O'Brien, J. T., Aarsland, D., Attems, J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160946 · Cited by 24
“The subunits are involved in tethering of the 19S regulatory complex to the 20S proteasome and serve to maintain the structural stability of the 20S proteasome [15].”
BackgroundE3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking
Werner, C. T., Viswanathan, R., Martin, J. A., Gobira, P. H., Mitra, S., Thomas, S. A., Wang, Z.-J., Liu, J., Stewart, A. F., Neve, R. L., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.07.013 · Cited by 25
“Polyubiquitin tags with K48 linkage are recognized and degraded by the 26S proteasome complex (6,10,11).”
BackgroundChapter 8 The Molecular and Cellular Pathogenesis of Dementia of the Alzheimer's Type
Luque, F. A., & Jaffe, S. L. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00408-5 · Cited by 24
A Ubiquitin E2 Variant Protein Acts in Axon Termination and Synaptogenesis in Caenorhabditis elegans
Trujillo, G., Nakata, K., Yan, D., MARUYAMA, I. N., & Jin, Y. (2010) · Genetics · doi:10.1534/genetics.110.117341 · Cited by 27
Kuznetsov, I. A., & Kuznetsov, A. V. (2016) · Mathematical Biosciences · doi:10.1016/j.mbs.2016.05.002 · Cited by 22
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease
Zetterberg, M., Sjölander, A., von Otter, M., Palmér, M. S., Landgren, S., Minthon, L., Wallin, A., Andreasen, N., Blennow, K., & Zetterberg, H. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-11 · Cited by 21
“For recent reviews on the UPS, see [2,3].”
Broekaart, D. W. M., van Scheppingen, J., Geijtenbeek, K. W., Zuidberg, M. R. J., Anink, J. J., Baayen, J. C., Mühlebner, A., Aronica, E., Gorter, J. A., & van Vliet, E. A. (2017) · Epilepsia · doi:10.1111/epi.13823 · Cited by 22
“The proteasome consists of a barrel-shaped core particle in combination with two possible regulatory particles.(4,5) The core particle, also known as the 20S core complex, consists of four heptameric rings positioned in an abba-stoichiometry.”
BackgroundCul4 ubiquitin ligase cofactor DCAF12 promotes neurotransmitter release and homeostatic plasticity
Patrón, L. A., Nagatomo, K., Eves, D. T., Imad, M., Young, K., Torvund, M., Guo, X., Rogers, G. C., & Zinsmaier, K. E. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201805099 · Cited by 22
“Ubiquitin-mediated signaling is regarded as a critical mechanism controlling synaptic plasticity, and its failure has been linked to numerous neurological, neurodegenerative, and psychiatric diseases (Tai and Schuman, 2008; Lehman, 2009; Mabb and Ehlers, 2010; Hegde, 2017).”
BackgroundMolecular biology of Huntington's disease
McFarland, K. N., & Cha, J.-H. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00003-3 · Cited by 23
Iwata, S., Morikawa, M., Takei, Y., & Hirokawa, N. (2020) · Science Advances · doi:10.1126/sciadv.abc8355 · Cited by 21
Yuan, R., Hahn, Y., Stempel, M. H., Sidibe, D. K., Laxton, O., Chen, J., Kulkarni, A., & Maday, S. (2022) · Autophagy · doi:10.1080/15548627.2022.2084884 · Cited by 20
“Consequently, dysfunction of the proteasome has been linked to the progression of various neurodegenerative diseases [30,31], potentially via a common mechanism by”
BackgroundSharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 21
Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta
Zhang, C., Jia, Q., Zhu, L., Hou, J., Wang, X., Li, D., Zhang, J., Zhang, Y., Su, Y., Tu, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14122 · Cited by 20
“13 16 Misfolded proteins are initially ubiquitinated and then targeted for degradation by the UPS or autophagy.”
STAMBPL1/TRIM21 Balances AXL Stability Impacting Mesenchymal Phenotype and Immune Response in KIRC
Huang, S., Qin, X., Fu, S., Hu, J., Jiang, Z., Hu, M., Zhang, B., Liu, J., Chen, Y., Wang, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202405083 · Cited by 22
Ryu, H.-W., Park, C., & Ryu, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.103 · Cited by 20
Victoria, G. S., & Zurzolo, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.019 · Cited by 22
Küry, S., Besnard, T., Ebstein, F., Khan, T. N., Gambin, T., Douglas, J., Bacino, C. A., Craigen, W. J., Sanders, S. J., Lehmann, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.03.003 · Cited by 19
Zhou, Q., Wang, W., & Deng, C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04838-0 · Cited by 21
“Research has indicated that the majority of protein aggregates in neurodegenerative diseases arise from decreased degradation rather than heightened synthesis [73].”
Targeting immunoproteasome in neurodegeneration: A glance to the future
Tundo, G. R., Cascio, P., Milardi, D., Santoro, A. M., Graziani, G., Lacal, P. M., Bocedi, A., Oddone, F., Parravano, M., Coletta, A., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108329 · Cited by 20
Olivero, P., Lozano, C., Sotomayor‐Zárate, R., Meza-Concha, N., Arancibia, M., Córdova, C., González‐Arriagada, W. A., Ramírez-Barrantes, R., & Marchant, I. (2018) · Neural Plasticity · doi:10.1155/2018/6798712 · Cited by 20
“Mutations in genes encoding for UPS proteins [25] have also been associated with the development of hereditary forms of neurodegenerative diseases.”
BackgroundImpaired proteostasis in rare neurological diseases
Osinalde, N., Duarri, A., Ramírez, J., Barrio, R., de Nanclares, G. P., & Mayor, U. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.10.007 · Cited by 19
Aging and diet alter the protein ubiquitylation landscape in the mouse brain
Marino, A., Fraia, D. D., Panfilova, D., Sahu, A. K., Minetti, A., Omrani, O., Cirri, E., & Ori, A. (2025) · Nature Communications · doi:10.1038/s41467-025-60542-6 · Cited by 18
“1E), and previous reports showed that synaptic transmission is controlled by UPS 12 .”
InfluentialBaranes, K., Hibsh, D., Cohen, S., Yamin, T., Efroni, S., Sharoni, A., & Shefi, O. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03879 · Cited by 18
Wang, T., Zhang, Y., Liu, Y., Huang, Y., & Wang, W. (2023) · Advanced Science · doi:10.1002/advs.202304791 · Cited by 20
Kumar, S. S., Naseri, N. N., Pather, S. R., Hallacli, E., Ndayisaba, A., Buenaventura, C., Acosta, K., Roof, J., Fazelinia, H., Spruce, L. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj4767 · Cited by 19
“Protein turnover of cytosolic proteins is typically regulated by the ubiquitin-proteasome system, whereas membrane-bound proteins generally rely on the endolysosomal degradation pathway ( 57 ).”
Jung, B.-K., Park, C., & Ryu, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-21032-6 · Cited by 18
Feldmann, L. K., Prieult, F. L., Felzen, V., Thal, S. C., Engelhard, K., Behl, C., & Mittmann, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123048 · Cited by 20
Role of the Ubiquitin System in Chronic Pain
Cheng, J., Deng, Y., & Zhou, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.674914 · Cited by 20
Khan, S. U., Khan, M. U., Kalsoom, F., Khan, M. I., Gao, S., Unar, A., Zubair, M., & Bilal, M. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02897-8 · Cited by 20
Extralysosomal Protein Degradation in Myofibrillar Myopathies
Olivé, M. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00288.x · Cited by 19
“In addition to ubiquitylating enzymes, additional factors including deubiquitylating enzymes, shuttling factors and chaperones are involved in presenting substrates to the proteasome for degradation (70).”
BackgroundNagamine, S., Kabuta, T., Furuta, A., Yamamoto, K., Takahashi, A., & Wada, K. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.015 · Cited by 18
Snapin deficiency is associated with developmental defects of the central nervous system
Zhou, B., Zhu, Y.-B., Lin, L., Cai, Q., & Sheng, Z. (2010) · Bioscience Reports · doi:10.1042/bsr20100110 · Cited by 18
Iris Garcia-martinez, A., Sánchez‐Mora, C., Artigas, M. S., Rovira, P., Pagerols, M., Corrales, M., Calvo-Sánchez, E., Richarte, V., Bustamante, M., Sunyer, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05514-7 · Cited by 18
The Drosophila LC8 homolog cut up specifies the axonal transport of proteasomes
Kreko‐Pierce, T., & Eaton, B. A. (2017) · Journal of Cell Science · doi:10.1242/jcs.207027 · Cited by 18
Csizmadia, V., Csizmadia, E., Silverman, L. R., Simpson, C., Raczynski, A. R., O’Brien, L., Gallacher, M., Cardoza, K., Kadambi, V. J., Fedyk, E. R., et al. (2010) · Veterinary Pathology · doi:10.1177/0300985809358423 · Cited by 18
“Protein aggregation is critical in many neurological diseases, with the UPS involved in the genesis of these inclusions.(13,28) Approximately 30% of newly synthesized proteins are misfolded in the normal cell.”
BackgroundFelix, R., & Weiss, N. (2017) · General Physiology and Biophysics · doi:10.4149/gpb_2016037 · Cited by 17
Structural insights into SMCR8 C-degron recognition by FEM1B
Zhao, S., Ru, W., Chen, X., Liao, S., Zhu, Z., Zhang, J., & Xu, C. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.046 · Cited by 17
Kushima, I., Aleksić, B., Ito, Y., Nakamura, Y., Nakamura, K., Mori, N., Kikuchi, M., Inada, T., Kunugi, H., Nanko, S., et al. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2009.139 · Cited by 20
Oxidation and ubiquitination in neurodegeneration
Riederer, B. M., Leuba, G., & ElHajj, Z. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213488484 · Cited by 19
“The UPS is instrumental for protein repair and turnover and consists of a complex multistep enzymatic pathway, being a special challenge for the postmitotic neurons to maintain synaptic plasticity and self-renewal.(4,32,33) Ubiquitin is a small molecule used to target damaged proteins for repair or proteins destined f…”
BackgroundIntegrating the analysis of human biopsies using post‐translational modifications proteomics
Bhardwaj, S., Bulluss, M., D’Aubeterre, A., Derakhshani, A., Penner, R., Mahajan, M., Mahajan, V. B., & Dufour, A. (2024) · Protein Science · doi:10.1002/pro.4979 · Cited by 16
Keeley, O., & Coyne, A. N. (2024) · Nucleus · doi:10.1080/19491034.2024.2349085 · Cited by 16
“Neurodegenerative diseases are often characterized by the presence of protein aggregates at end-stage disease [85,224–230].”
BackgroundSimultaneous Detection of Distinct Ubiquitin Chain Topologies by 19F NMR
Shekhawat, S. S., Pham, G. H., Prabakaran, J., & Strieter, E. R. (2014) · ACS Chemical Biology · doi:10.1021/cb500589c · Cited by 16
Türker, F., Bharadwaj, R. A., Kleinman, J. E., Weinberger, D. R., Hyde, T. M., White, C. J., Williams, D. W., & Margolis, S. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104811 · Cited by 16
“Despite widespread use, several features of AMC substrates limit their utility in measuring proteasome activity: (1) The peptide-based substrates are not cell-permeable, limiting the use of this technique to purified proteasomes or cell/tissue lysates.”
BackgroundMethodResultInfluentialZimmermann, C. A., Arloth, J., Santarelli, S., Loeschner, A., Weber, P. C., Schmidt, M. V., Spengler, D., & Binder, E. B. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0373-1 · Cited by 17
RNPS 1 is modulated by ubiquitin‐specific protease 4
Kwon, S., Kim, E., & Baek, K. (2016) · FEBS Letters · doi:10.1002/1873-3468.12531 · Cited by 16
Proteostasis, disease and the ageing neuron: Compartmental complexity in non-renewing cells
Coleman, R. A., Johnson, M. E., Konopka, A., & Chew, Y. L. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103073 · Cited by 15
MeCP2 ubiquitination and sumoylation, in search of a function
Kalani, L., Kim, B.-H., Vincent, J. B., & Ausió, J. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad150 · Cited by 15
Small-molecule activators of NRF1 transcriptional activity prevent protein aggregation
Sedláček, J., Šmahelová, Z., Adamek, M., Subova, D., Svobodová, L., Kadlecová, A., Majer, P., Machara, A., & Šašková, K. G. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117864 · Cited by 15
The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface Ca V 2.2 channels
Gandini, M. A., Sandoval, A., Zamponi, G. W., & Felix, R. (2014) · Channels · doi:10.4161/19336950.2014.949162 · Cited by 15
“This is of particular physiological relevance since it has been shown that the inhibition of the UPS may lead to increases in synaptic efficacy and neurotransmission.(13)”
BackgroundIbarra-Bracamontes, V., Escobar‐Herrera, J., Krištofíková, Z., Řípová, D., Florán, B., & García‐Sierra, F. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146953 · Cited by 15
Rajput, K., Afridi, H. I., Kazi, T. G., Talpur, F. N., & Baig, J. A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02399-y · Cited by 15
Richman, S. A., Wang, L.-C., Moon, E. K., Khire, U. R., Albelda, S. Μ., & Milone, M. C. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.010 · Cited by 15
Drugs for Targeted Therapies of Alzheimer’s Disease
Tam, C., Wong, J. H., Ng, T. B., Tsui, S. K., & Zuo, T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180430150940 · Cited by 15
Contemporary trends in targeted protein degradation for neurodegenerative diseases
Kumar, G., Thakur, V., Sardana, S., Tiwari, V. K., Sharma, D., & Kumar, A. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118110 · Cited by 15
Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators
Morozov, A. V., Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen’ev, M. B., Sharova, N. P., Карпов, В. Л., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160491 · Cited by 14
“11S regulator (hatched) is a heptameric ring of ( 11S) and subunits [65].”
Background
Metadata
- Authors
- Tai, H.-C., & Schuman, E. M.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Schuman, Erin M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2008-11
- Volume
- 9
- Issue
- 11
- Pages
- 826-838
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2060776482
- Cited by
- 532
- References
- 148
- Citations by year
- 2026: 18 · 2025: 34 · 2024: 36 · 2023: 28 · 2022: 28 · 2021: 35 · 2020: 32 · 2019: 25 · 2018: 28 · 2017: 36 · 2016: 27 · 2015: 21 · 2014: 32 · 2013: 29 · 2012: 33
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- ubiquitin, proteasome, protein degradation, neurons, neurodegenerative diseases, lysosomes, postmitotic neurons, synaptic plasticity, protein aggregates, substrate supply
- MeSH terms
- Animals, Humans, Neurons, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.